Recruiting
Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
NCT04494503
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Guangxi Medical University Affiliated Tumor Hospital Nanning, Guangxi, China